Active Trading Blog

The IPOX® Week, April 22, 2019

Most Indexes fall ahead of earnings as health care stocks, high-beta decline; IPOX China (CNI) gains against trend. 15.39% of IPOX 100 U.S. (ETF: FPX) market cap set to report. IPO Deal-flow Review & Outlook: Euphoric U.S. IPO market faced the busiest week YTD as global IPOs leave USD billion 1.07 “on the table”. Hong.. Read more

Cannabis Has A Banking Problem, But A Solution May Be On The Horizon

By: Spencer Israel This will go down as the decade where cannabis went from the frontier to the mainstream. It was only in 2012 that Colorado and Washington became the first two states to legalize recreational marijuana. By 2014, so had Alaska, Oregon, and Washington D.C. By 2016, five more states had done so. Today,.. Read more

The IPOX® Week, April 15, 2019

“FPX” ETF celebrates 13th listing anniversary with market-beating returns, underlying IPOX 100 U.S. (IPXO) closes out trading week at fresh All-Time High. Takeover announcements for IPOX Holdings continue to roll in. IPO Deal-flow Review & Outlook: U.S. & European IPOs surge on strong demand for specialty firms. Ride-hailing giant Uber officially files to list on.. Read more

Previewing the Q2 Earnings Season: Expect A Weak Quarter

By: Spencer Israel Corporate earnings got off to a very inauspicious start in 2019. On just the second day of the year, Apple ($AAPL) lowered its Q1 sales guidance due to  slower-than-expected iPhone sales, a dramatic headline that sent shockwaves through Wall Street. And Apple was not the only company to provide weak guidance, which.. Read more

The IPOX® Week, April 8, 2019

IPOX Europe (ETF: FPXE) leads IPOX Indexes to strong week. After hitting an all-time high Wednesday, IPOX U.S. (ETF: FPX) rises, but lags as U.S. Market plays catch-up. IPO Deal-flow Review & Outlook: Electronic trading platform Tradeweb Markets (TW US) debuts strongly. IPOX Europe (ETF: FPXE) in focus as attractive European IPOs & Novartis (NVS.. Read more

Try the demo

Compare Platforms
Check the background of this firm on FINRA's BrokerCheck

Our website uses cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site in our Privacy Policy. By clicking OK, you agree to allow us to collect information through cookies.